249 related articles for article (PubMed ID: 25791755)
21. Next generation sequencing reveals genetic landscape of hepatocellular carcinomas.
Li S; Mao M
Cancer Lett; 2013 Nov; 340(2):247-53. PubMed ID: 23063663
[TBL] [Abstract][Full Text] [Related]
22. Methods in virus diagnostics: from ELISA to next generation sequencing.
Boonham N; Kreuze J; Winter S; van der Vlugt R; Bergervoet J; Tomlinson J; Mumford R
Virus Res; 2014 Jun; 186():20-31. PubMed ID: 24361981
[TBL] [Abstract][Full Text] [Related]
23. Translational bioinformatics for diagnostic and prognostic prediction of prostate cancer in the next-generation sequencing era.
Chen J; Zhang D; Yan W; Yang D; Shen B
Biomed Res Int; 2013; 2013():901578. PubMed ID: 23957008
[TBL] [Abstract][Full Text] [Related]
24. Reprint of: The prostate cancer genome: Perspectives and potential.
Barbieri CE; Tomlins SA
Urol Oncol; 2015 Feb; 33(2):95-102. PubMed ID: 25726356
[TBL] [Abstract][Full Text] [Related]
25. [Personalized medicine and prostate cancer. The reality of change].
Carballido Rodríguez JA; Martínez-Salamanca JI
Arch Esp Urol; 2015 Apr; 68(3):391-400. PubMed ID: 25948808
[TBL] [Abstract][Full Text] [Related]
26. Sequencing the transcriptional network of androgen receptor in prostate cancer.
Chng KR; Cheung E
Cancer Lett; 2013 Nov; 340(2):254-60. PubMed ID: 23196061
[TBL] [Abstract][Full Text] [Related]
27. The emerging roles of NGS in clinical oncology and personalized medicine.
Hussen BM; Abdullah ST; Salihi A; Sabir DK; Sidiq KR; Rasul MF; Hidayat HJ; Ghafouri-Fard S; Taheri M; Jamali E
Pathol Res Pract; 2022 Feb; 230():153760. PubMed ID: 35033746
[TBL] [Abstract][Full Text] [Related]
28. [Genome sequencing and personalized medicine: perspectives and limitations].
Le Gall JY; Debré P;
Bull Acad Natl Med; 2014 Jan; 198(1):101-17. PubMed ID: 26259290
[TBL] [Abstract][Full Text] [Related]
29. [Recent advancements in prostate cancer basic research].
Inoue T; Ogawa O
Nihon Rinsho; 2016 Jan; 74(1):7-12. PubMed ID: 26793872
[TBL] [Abstract][Full Text] [Related]
30. Label-free screening of single biomolecules through resistive pulse sensing technology for precision medicine applications.
Harrer S; Kim SC; Schieber C; Kannam S; Gunn N; Moore S; Scott D; Bathgate R; Skafidas S; Wagner JM
Nanotechnology; 2015 May; 26(18):182502. PubMed ID: 25875197
[TBL] [Abstract][Full Text] [Related]
31. Development and analytical validation of a 25-gene next generation sequencing panel that includes the BRCA1 and BRCA2 genes to assess hereditary cancer risk.
Judkins T; Leclair B; Bowles K; Gutin N; Trost J; McCulloch J; Bhatnagar S; Murray A; Craft J; Wardell B; Bastian M; Mitchell J; Chen J; Tran T; Williams D; Potter J; Jammulapati S; Perry M; Morris B; Roa B; Timms K
BMC Cancer; 2015 Apr; 15():215. PubMed ID: 25886519
[TBL] [Abstract][Full Text] [Related]
32. Whole-genome and Transcriptome Sequencing of Prostate Cancer Identify New Genetic Alterations Driving Disease Progression.
Ren S; Wei GH; Liu D; Wang L; Hou Y; Zhu S; Peng L; Zhang Q; Cheng Y; Su H; Zhou X; Zhang J; Li F; Zheng H; Zhao Z; Yin C; He Z; Gao X; Zhau HE; Chu CY; Wu JB; Collins C; Volik SV; Bell R; Huang J; Wu K; Xu D; Ye D; Yu Y; Zhu L; Qiao M; Lee HM; Yang Y; Zhu Y; Shi X; Chen R; Wang Y; Xu W; Cheng Y; Xu C; Gao X; Zhou T; Yang B; Hou J; Liu L; Zhang Z; Zhu Y; Qin C; Shao P; Pang J; Chung LWK; Xu J; Wu CL; Zhong W; Xu X; Li Y; Zhang X; Wang J; Yang H; Wang J; Huang H; Sun Y
Eur Urol; 2018 Mar; 73(3):322-339. PubMed ID: 28927585
[TBL] [Abstract][Full Text] [Related]
33. Development of a Center for Personalized Cancer Care at a Regional Cancer Center: Feasibility Trial of an Institutional Tumor Sequencing Advisory Board.
Lane BR; Bissonnette J; Waldherr T; Ritz-Holland D; Chesla D; Cottingham SL; Alberta S; Liu C; Thompson AB; Graveel C; MacKeigan JP; Noyes SL; Smith J; Lakhani N; Steensma MR;
J Mol Diagn; 2015 Nov; 17(6):695-704. PubMed ID: 26331835
[TBL] [Abstract][Full Text] [Related]
34. Contemporary role of prostate cancer antigen 3 in the management of prostate cancer.
Auprich M; Bjartell A; Chun FK; de la Taille A; Freedland SJ; Haese A; Schalken J; Stenzl A; Tombal B; van der Poel H
Eur Urol; 2011 Nov; 60(5):1045-54. PubMed ID: 21871709
[TBL] [Abstract][Full Text] [Related]
35. Application of next-generation sequencing in gastrointestinal and liver tumors.
Mikhail S; Faltas B; Salem ME; Bekaii-Saab T
Cancer Lett; 2016 May; 374(2):187-91. PubMed ID: 26916979
[TBL] [Abstract][Full Text] [Related]
36. Fishing the targets of myeloid malignancies in the era of next generation sequencing.
Shi X; He BL; Ma AC; Leung AY
Blood Rev; 2016 Mar; 30(2):119-30. PubMed ID: 26443083
[TBL] [Abstract][Full Text] [Related]
37. Comprehensive next-generation cancer genome sequencing in the era of targeted therapy and personalized oncology.
Cronin M; Ross JS
Biomark Med; 2011 Jun; 5(3):293-305. PubMed ID: 21657839
[TBL] [Abstract][Full Text] [Related]
38. Endoscopic ultrasound fine-needle aspiration cytology mutation profiling using targeted next-generation sequencing: personalized care for rectal cancer.
Gleeson FC; Kipp BR; Voss JS; Campion MB; Minot DM; Tu ZJ; Klee EW; Sciallis AP; Graham RP; Lazaridis KN; Henry MR; Levy MJ
Am J Clin Pathol; 2015 Jun; 143(6):879-88. PubMed ID: 25972331
[TBL] [Abstract][Full Text] [Related]
39. Whole Exome Sequencing Identifies Putative Predictors of Recurrent Prostate Cancer with High Accuracy.
Liu J; Mao R; Ren G; Liu X; Zhang Y; Wang J; Wang Y; Li M; Qiu Q; Wang L; Liu G; Jin S; Ma L; Ma Y; Zhao N; Yan J; Zhang H; Lin B
OMICS; 2019 Aug; 23(8):380-388. PubMed ID: 31194651
[TBL] [Abstract][Full Text] [Related]
40. Identification of novel TMPRSS2:ERG mechanisms in prostate cancer metastasis: involvement of MMP9 and PLXNA2.
Tian TV; Tomavo N; Huot L; Flourens A; Bonnelye E; Flajollet S; Hot D; Leroy X; de Launoit Y; Duterque-Coquillaud M
Oncogene; 2014 Apr; 33(17):2204-14. PubMed ID: 23708657
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
